Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value: $707M (100.0% shares, 0.0% debt)

Holdings (22)

NUVB Nuvation Bio 27.6%

Value $195M Shares 22,957,340 Est. Cost $11.18 Unrealized -17.8%

REPL Replimune Group 18.3%

Value $129M Shares 4,763,380 Est. Cost $17.40 Unrealized +71.9%

— Imago Biosciences 10.1%

Value $71.57M Shares 3,018,737 Est. Cost $20.03 Unrealized —

— Morphic Holding 8.0%

Value $56.86M Shares 1,200,014 Est. Cost $19.82 Unrealized —

— Kronos Bio 7.3%

Value $51.89M Shares 3,818,283 Est. Cost $29.87 Unrealized —

GOSS Gossamer Bio 5.1%

Value $35.79M Shares 3,164,835 Est. Cost $20.85 Unrealized -43.0%

— Ikena Oncology 4.0%

Value $28.2M Shares 2,249,123 Est. Cost $28.25 Unrealized —

— Alpine Immune Sciences 4.0%

Value $28.11M Shares 2,029,580 Est. Cost $9.48 Unrealized —

IMUX Immunic Inc 2.4%

Value $17.11M Shares 1,788,160 Est. Cost $13.89 Unrealized -35.2%

SANA Sana Biotechnology, Inc. 1.8%

Value $13.06M Shares 843,750 Est. Cost $32.56 Unrealized -40.8%

ARQT Arcutis Biothereapeutics 1.8%

Value $12.94M Shares 623,836 Est. Cost $26.87 Unrealized -25.9%

— Icosavax 1.4%

Value $9.756M Shares 426,395 Est. Cost $29.59 Unrealized —

— Spruce Biosciences 1.4%

Value $9.638M Shares 2,161,022 Est. Cost $24.31 Unrealized —

— Theseus Pharmaceuticals 1.3%

Value $9.022M Shares 711,479 Est. Cost $12.68 Unrealized —

— Paratek Pharmaceuticals 1.3%

Value $8.851M Shares 1,971,241 Est. Cost $34.18 Unrealized —

— Syros Pharmaceuticals 1.2%

Value $8.191M Shares 2,512,705 Est. Cost $8.72 Unrealized —

— Omega Alpha SPAC 0.7%

Value $4.895M Shares 501,000 Est. Cost $9.98 Unrealized —

— ESSA Pharma 0.7%

Value $4.66M Shares 328,196 Est. Cost $3.14 Unrealized —

IVVD Adagio Therapeutics 0.6%

Value $4.595M Shares 632,855 Est. Cost $37.11 Unrealized -29.9%

— Checkmate Pharmaceuticals 0.5%

Value $3.832M Shares 1,335,050 Est. Cost $11.51 Unrealized —

— Jounce Therapeutics 0.3%

Value $2.301M Shares 275,513 Est. Cost $21.99 Unrealized —

IMCR Immunocore Holdings 0.2%

Value $1.765M Shares 51,535 Est. Cost $42.57 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NUVB	Nuvation Bio	22,957,340	$195M	27.6%	$11.18	-17.8%	Class A Common Stock	67080N101
REPL	Replimune Group	4,763,380	$129M	18.3%	$17.40	+71.9%	Common Stock	76029N106
—	Imago Biosciences	3,018,737	$71.57M	10.1%	$20.03	—	Common Stock	45250K107
—	Morphic Holding	1,200,014	$56.86M	8.0%	$19.82	—	Common Stock	61775R105
—	Kronos Bio	3,818,283	$51.89M	7.3%	$29.87	—	Common Stock	50107A104
GOSS	Gossamer Bio	3,164,835	$35.79M	5.1%	$20.85	-43.0%	Common Stock	38341P102
—	Ikena Oncology	2,249,123	$28.2M	4.0%	$28.25	—	Common Stock	45175G108
—	Alpine Immune Sciences	2,029,580	$28.11M	4.0%	$9.48	—	Common Stock	02083G100
IMUX	Immunic Inc	1,788,160	$17.11M	2.4%	$13.89	-35.2%	Common Stock	4525EP101
SANA	Sana Biotechnology, Inc.	843,750	$13.06M	1.8%	$32.56	-40.8%	Common Stock	799566104
ARQT	Arcutis Biothereapeutics	623,836	$12.94M	1.8%	$26.87	-25.9%	Common Stock	03969K108
—	Icosavax	426,395	$9.756M	1.4%	$29.59	—	Common Stock	45114M109
—	Spruce Biosciences	2,161,022	$9.638M	1.4%	$24.31	—	Common Stock	85209E109
—	Theseus Pharmaceuticals	711,479	$9.022M	1.3%	$12.68	—	Common Stock	88369M101
—	Paratek Pharmaceuticals	1,971,241	$8.851M	1.3%	$34.18	—	Common Stock	699374302
—	Syros Pharmaceuticals	2,512,705	$8.191M	1.2%	$8.72	—	Common Stock	87184Q107
—	Omega Alpha SPAC	501,000	$4.895M	0.7%	$9.98	—	Class A Common Stock	G6749V107
—	ESSA Pharma	328,196	$4.66M	0.7%	$3.14	—	Common Stock	29668H708
IVVD	Adagio Therapeutics	632,855	$4.595M	0.6%	$37.11	-29.9%	Common Stock	00534A102
—	Checkmate Pharmaceuticals	1,335,050	$3.832M	0.5%	$11.51	—	Common Stock	162818108
—	Jounce Therapeutics	275,513	$2.301M	0.3%	$21.99	—	Common Stock	481116101
IMCR	Immunocore Holdings	51,535	$1.765M	0.2%	$42.57	—	Common Stock	45258D105